APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrin Alpha V

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Integrin Alpha V Industry Growth and Trends Forecast to 2032

19 December 202585 pages

Choose your research edition.

Industry ResearchIntegrin Alpha V Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrin Alpha V Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Integrin Alpha V Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrin Alpha V Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrin Alpha V Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Integrin Alpha V market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrin Alpha V is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Integrin Alpha V market include Merck & Co Inc, Biogen Inc, Vascular Pharmaceuticals Inc, SciFluor Life Sciences LLC, Morphic Therapeutic Inc, Merck KGaA, MedImmune LLC, Factor Therapeutics Ltd and BioMAS Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Integrin Alpha V market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Integrin Alpha V market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Integrin Alpha V market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Integrin Alpha V.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Integrin Alpha V market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Integrin Alpha V Market by Company

Merck & Co Inc

Biogen Inc

Vascular Pharmaceuticals Inc

SciFluor Life Sciences LLC

Morphic Therapeutic Inc

Merck KGaA

MedImmune LLC

Factor Therapeutics Ltd

BioMAS Ltd

Integrin Alpha V Segment by Type

MK-0429

C-16Y

AC-301

264-RAD

Others

Integrin Alpha V Segment by Application

Ophthalmology

Respiratory

Metabolic Disorders

Infectious Disease

Others

Integrin Alpha V Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrin Alpha V market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrin Alpha V and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrin Alpha V.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Integrin Alpha V companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Integrin Alpha V Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Integrin Alpha V Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Integrin Alpha V Market Share by Region (2021-2026) Table 4. Global Integrin Alpha V Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Integrin Alpha V Market Share by Region (2027-2032) Table 6. Global Integrin Alpha V Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Integrin Alpha V Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Integrin Alpha V Market Size Share by Type (2021-2026) Table 9. Global Integrin Alpha V Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Integrin Alpha V Market Size Share Forecasted by Type (2027-2032) Table 11. North America Integrin Alpha V Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Integrin Alpha V Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Integrin Alpha V Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Integrin Alpha V Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Integrin Alpha V Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Integrin Alpha V Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Integrin Alpha V Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Integrin Alpha V Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Integrin Alpha V Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Integrin Alpha V Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Integrin Alpha V Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Integrin Alpha V Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Integrin Alpha V Market Size Share by Application (2021-2026) Table 24. Global Integrin Alpha V Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Integrin Alpha V Market Size Share Forecasted by Application (2027-2032) Table 26. North America Integrin Alpha V Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Integrin Alpha V Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Integrin Alpha V Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Integrin Alpha V Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Integrin Alpha V Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Integrin Alpha V Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Integrin Alpha V Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Integrin Alpha V Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Integrin Alpha V Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Integrin Alpha V Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Integrin Alpha V Industry Trends Table 37. Integrin Alpha V Industry Drivers Table 38. Integrin Alpha V Industry Opportunities and Challenges Table 39. Integrin Alpha V Industry Restraints Table 40. Global Integrin Alpha V Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Integrin Alpha V Revenue Market Share by Company (2021-2026) Table 42. Global Integrin Alpha V Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Integrin Alpha V Key Company Headquarters & Area Served Table 44. Global Integrin Alpha V Company, Product Type & Application Table 45. Global Integrin Alpha V Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Integrin Alpha V by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Merck & Co Inc Company Information Table 49. Merck & Co Inc Business Overview Table 50. Merck & Co Inc Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Merck & Co Inc Integrin Alpha V Product Portfolio Table 52. Merck & Co Inc Recent Development Table 53. Biogen Inc Company Information Table 54. Biogen Inc Business Overview Table 55. Biogen Inc Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Biogen Inc Integrin Alpha V Product Portfolio Table 57. Biogen Inc Recent Development Table 58. Vascular Pharmaceuticals Inc Company Information Table 59. Vascular Pharmaceuticals Inc Business Overview Table 60. Vascular Pharmaceuticals Inc Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Vascular Pharmaceuticals Inc Integrin Alpha V Product Portfolio Table 62. Vascular Pharmaceuticals Inc Recent Development Table 63. SciFluor Life Sciences LLC Company Information Table 64. SciFluor Life Sciences LLC Business Overview Table 65. SciFluor Life Sciences LLC Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. SciFluor Life Sciences LLC Integrin Alpha V Product Portfolio Table 67. SciFluor Life Sciences LLC Recent Development Table 68. Morphic Therapeutic Inc Company Information Table 69. Morphic Therapeutic Inc Business Overview Table 70. Morphic Therapeutic Inc Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Morphic Therapeutic Inc Integrin Alpha V Product Portfolio Table 72. Morphic Therapeutic Inc Recent Development Table 73. Merck KGaA Company Information Table 74. Merck KGaA Business Overview Table 75. Merck KGaA Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merck KGaA Integrin Alpha V Product Portfolio Table 77. Merck KGaA Recent Development Table 78. MedImmune LLC Company Information Table 79. MedImmune LLC Business Overview Table 80. MedImmune LLC Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. MedImmune LLC Integrin Alpha V Product Portfolio Table 82. MedImmune LLC Recent Development Table 83. Factor Therapeutics Ltd Company Information Table 84. Factor Therapeutics Ltd Business Overview Table 85. Factor Therapeutics Ltd Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Factor Therapeutics Ltd Integrin Alpha V Product Portfolio Table 87. Factor Therapeutics Ltd Recent Development Table 88. BioMAS Ltd Company Information Table 89. BioMAS Ltd Business Overview Table 90. BioMAS Ltd Integrin Alpha V Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. BioMAS Ltd Integrin Alpha V Product Portfolio Table 92. BioMAS Ltd Recent Development Table 93. North America Integrin Alpha V Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Integrin Alpha V Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Integrin Alpha V Market Share by Country (2021-2026) Table 96. North America Integrin Alpha V Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Integrin Alpha V Market Share Forecast by Country (2027-2032) Table 98. Europe Integrin Alpha V Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Integrin Alpha V Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Integrin Alpha V Market Share by Country (2021-2026) Table 101. Europe Integrin Alpha V Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Integrin Alpha V Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Integrin Alpha V Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Integrin Alpha V Market Size by Country (2021-2026) & (US$ Million) Table 105. Asia-Pacific Integrin Alpha V Market Share by Country (2021-2026) Table 106. Asia-Pacific Integrin Alpha V Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Asia-Pacific Integrin Alpha V Market Share Forecast by Country (2027-2032) Table 108. Latin America Integrin Alpha V Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Latin America Integrin Alpha V Market Size by Country (2021-2026) & (US$ Million) Table 110. Latin America Integrin Alpha V Market Share by Country (2021-2026) Table 111. Latin America Integrin Alpha V Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Latin America Integrin Alpha V Market Share Forecast by Country (2027-2032) Table 113. Middle East & Africa Integrin Alpha V Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Middle East & Africa Integrin Alpha V Market Size by Country (2021-2026) & (US$ Million) Table 115. Middle East & Africa Integrin Alpha V Market Share by Country (2021-2026) Table 116. Middle East & Africa Integrin Alpha V Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Middle East & Africa Integrin Alpha V Market Share Forecast by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Integrin Alpha V Product Image Figure 3. Global Integrin Alpha V Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Integrin Alpha V Market Size (2021-2032) & (US$ Million) Figure 5. Global Integrin Alpha V Market Share by Region: 2025 VS 2032 Figure 6. Global Integrin Alpha V Market Share by Region (2021-2032) Figure 7. North America Integrin Alpha V Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Integrin Alpha V Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Integrin Alpha V Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Integrin Alpha V Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Integrin Alpha V Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. MK-0429 Image Figure 13. Global MK-0429 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. C-16Y Image Figure 15. Global C-16Y Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. AC-301 Image Figure 17. Global AC-301 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. 264-RAD Image Figure 19. Global 264-RAD Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Integrin Alpha V Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Integrin Alpha V Market Share by Type 2025 VS 2032 Figure 24. North America Integrin Alpha V Market Size Share by Type (2021-2032) Figure 25. Europe Integrin Alpha V Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Integrin Alpha V Market Size Share by Type (2021-2032) Figure 27. Latin America Integrin Alpha V Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Integrin Alpha V Market Size Share by Type (2021-2032) Figure 29. Ophthalmology Image Figure 30. Global Ophthalmology Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Respiratory Image Figure 32. Global Respiratory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Metabolic Disorders Image Figure 34. Global Metabolic Disorders Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Infectious Disease Image Figure 36. Global Infectious Disease Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Integrin Alpha V Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Integrin Alpha V Market Share by Application 2025 VS 2032 Figure 41. North America Integrin Alpha V Market Size Share by Application (2021-2032) Figure 42. Europe Integrin Alpha V Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Integrin Alpha V Market Size Share by Application (2021-2032) Figure 44. Latin America Integrin Alpha V Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Integrin Alpha V Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Integrin Alpha V Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Integrin Alpha V Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Integrin Alpha V Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Integrin Alpha V Market Share by Country (2021-2032) Figure 51. Europe Integrin Alpha V Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Integrin Alpha V Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Integrin Alpha V Market Share by Country (2021-2032) Figure 54. Asia-Pacific Integrin Alpha V Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Integrin Alpha V Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Integrin Alpha V Market Share by Country (2021-2032) Figure 57. Latin America Integrin Alpha V Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Integrin Alpha V Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Integrin Alpha V Market Share by Country (2021-2032) Figure 60. Middle East & Africa Integrin Alpha V Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Integrin Alpha V Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Integrin Alpha V Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • MK-0429
  • C-16Y
  • AC-301
  • 264-RAD
  • Others
Applications
  • Ophthalmology
  • Respiratory
  • Metabolic Disorders
  • Infectious Disease
  • Others
Companies covered
  • Merck & Co Inc
  • Biogen Inc
  • Vascular Pharmaceuticals Inc
  • SciFluor Life Sciences LLC
  • Morphic Therapeutic Inc
  • Merck KGaA
  • MedImmune LLC
  • Factor Therapeutics Ltd
  • BioMAS Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Integrin Alpha V Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Integrin Alpha V Market Size by Region (2021-2032)
  5. 1.4.1 Global Integrin Alpha V Market Size by Region (2021-2026)
  6. 1.4.2 Global Integrin Alpha V Market Size by Region (2027-2032)
  7. 1.5 Key Regions Integrin Alpha V Market Size (2021-2032)
  8. 1.5.1 North America Integrin Alpha V Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Integrin Alpha V Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Integrin Alpha V Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Integrin Alpha V Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Integrin Alpha V Market Size Growth Rate (2021-2032)
2 Integrin Alpha V Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 MK-0429
  3. 2.1.2 C-16Y
  4. 2.1.3 AC-301
  5. 2.1.4 264-RAD
  6. 2.1.5 Others
  7. 2.2 Global Integrin Alpha V Market Size by Type
  8. 2.2.1 Global Integrin Alpha V Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Integrin Alpha V Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Integrin Alpha V Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Integrin Alpha V Market Size by Regions
  12. 2.3.1 North America Integrin Alpha V Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Integrin Alpha V Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Integrin Alpha V Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Integrin Alpha V Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Integrin Alpha V Market Size Breakdown by Type (2021-2026)
3 Integrin Alpha V Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Ophthalmology
  3. 3.1.2 Respiratory
  4. 3.1.3 Metabolic Disorders
  5. 3.1.4 Infectious Disease
  6. 3.1.5 Others
  7. 3.2 Global Integrin Alpha V Market Size by Application
  8. 3.2.1 Global Integrin Alpha V Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Integrin Alpha V Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Integrin Alpha V Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Integrin Alpha V Market Size by Regions
  12. 3.3.1 North America Integrin Alpha V Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Integrin Alpha V Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Integrin Alpha V Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Integrin Alpha V Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Integrin Alpha V Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Integrin Alpha V Industry Trends
  2. 4.2 Integrin Alpha V Industry Drivers
  3. 4.3 Integrin Alpha V Industry Opportunities and Challenges
  4. 4.4 Integrin Alpha V Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Integrin Alpha V Revenue (2021-2026)
  2. 5.2 Global Integrin Alpha V Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Integrin Alpha V Key Company Headquarters & Area Served
  4. 5.4 Global Integrin Alpha V Company, Product Type & Application
  5. 5.5 Global Integrin Alpha V Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Integrin Alpha V Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Integrin Alpha V Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Integrin Alpha V Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Merck & Co Inc
  2. 6.1.1 Merck & Co Inc Company Information
  3. 6.1.2 Merck & Co Inc Business Overview
  4. 6.1.3 Merck & Co Inc Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co Inc Integrin Alpha V Product Portfolio
  6. 6.1.5 Merck & Co Inc Recent Developments
  7. 6.2 Biogen Inc
  8. 6.2.1 Biogen Inc Company Information
  9. 6.2.2 Biogen Inc Business Overview
  10. 6.2.3 Biogen Inc Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Biogen Inc Integrin Alpha V Product Portfolio
  12. 6.2.5 Biogen Inc Recent Developments
  13. 6.3 Vascular Pharmaceuticals Inc
  14. 6.3.1 Vascular Pharmaceuticals Inc Company Information
  15. 6.3.2 Vascular Pharmaceuticals Inc Business Overview
  16. 6.3.3 Vascular Pharmaceuticals Inc Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Vascular Pharmaceuticals Inc Integrin Alpha V Product Portfolio
  18. 6.3.5 Vascular Pharmaceuticals Inc Recent Developments
  19. 6.4 SciFluor Life Sciences LLC
  20. 6.4.1 SciFluor Life Sciences LLC Company Information
  21. 6.4.2 SciFluor Life Sciences LLC Business Overview
  22. 6.4.3 SciFluor Life Sciences LLC Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 SciFluor Life Sciences LLC Integrin Alpha V Product Portfolio
  24. 6.4.5 SciFluor Life Sciences LLC Recent Developments
  25. 6.5 Morphic Therapeutic Inc
  26. 6.5.1 Morphic Therapeutic Inc Company Information
  27. 6.5.2 Morphic Therapeutic Inc Business Overview
  28. 6.5.3 Morphic Therapeutic Inc Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Morphic Therapeutic Inc Integrin Alpha V Product Portfolio
  30. 6.5.5 Morphic Therapeutic Inc Recent Developments
  31. 6.6 Merck KGaA
  32. 6.6.1 Merck KGaA Company Information
  33. 6.6.2 Merck KGaA Business Overview
  34. 6.6.3 Merck KGaA Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merck KGaA Integrin Alpha V Product Portfolio
  36. 6.6.5 Merck KGaA Recent Developments
  37. 6.7 MedImmune LLC
  38. 6.7.1 MedImmune LLC Company Information
  39. 6.7.2 MedImmune LLC Business Overview
  40. 6.7.3 MedImmune LLC Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 MedImmune LLC Integrin Alpha V Product Portfolio
  42. 6.7.5 MedImmune LLC Recent Developments
  43. 6.8 Factor Therapeutics Ltd
  44. 6.8.1 Factor Therapeutics Ltd Company Information
  45. 6.8.2 Factor Therapeutics Ltd Business Overview
  46. 6.8.3 Factor Therapeutics Ltd Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Factor Therapeutics Ltd Integrin Alpha V Product Portfolio
  48. 6.8.5 Factor Therapeutics Ltd Recent Developments
  49. 6.9 BioMAS Ltd
  50. 6.9.1 BioMAS Ltd Company Information
  51. 6.9.2 BioMAS Ltd Business Overview
  52. 6.9.3 BioMAS Ltd Integrin Alpha V Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 BioMAS Ltd Integrin Alpha V Product Portfolio
  54. 6.9.5 BioMAS Ltd Recent Developments
7 North America
  1. 7.1 North America Integrin Alpha V Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Integrin Alpha V Market Size by Country (2021-2026)
  3. 7.3 North America Integrin Alpha V Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Integrin Alpha V Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Integrin Alpha V Market Size by Country (2021-2026)
  3. 8.3 Europe Integrin Alpha V Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Integrin Alpha V Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Integrin Alpha V Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Integrin Alpha V Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Integrin Alpha V Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Integrin Alpha V Market Size by Country (2021-2026)
  3. 10.3 South America Integrin Alpha V Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Integrin Alpha V Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Integrin Alpha V Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Integrin Alpha V Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst